Surgery in the primary treatment of breast cancer
Tóm tắt
Information available from NSABP protocols has contributed to an altered biological perception of breast cancer. The results of these studies lend support to a hypothesis which postulates that alterations in the loco-regional treatment of primary breast cancer will not change the natural history of the disease relative to distant metastasis and survivorship. Data from NSABP Protocol B-04 indicate that radical mastectomy provides no advantage over total mastectomy in clinically node-negative patients. Since 39% of this population had histologically positive nodes it may be concluded that leaving histologically positive nodes untreated results in no disadvantage. NSABP Protocol B-04 made available the scientific rationale for the study of breast-preserving operations in which the clinical significance of multicentricity will be determined. Although there is a sound scientific basis for the consideration of segmental mastectomy, there are no data available to justify the utilization of the procedure outside the context of a clinical trial. With the increased popularity and implementation of breast-preserving operations without the necessary supporting data, a potentially dangerous situation has been created which threatens to undermine the clinical trial process.
Tài liệu tham khảo
Fisher B: A commentary on the role of the surgeon in primary breast cancer. Breast Cancer Res Treat 1:17–26, 1981
Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 152:765–772, 1981
Fisher B, Redmond C, Brown A, Wolmark N, Wittliff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J, Frelick R, Desser R, LiCalzi N, Geggie P, Campbell T, Elias G, Prager D, Koontz P, Volk H, Dimitrov N, Gardner B, Lerner H, Shibata H, and Other NSABP Investigators: The treatment of primary breast cancer with chemotherapy and tamoxifen. New Engl J Med 305:1–6, 1981
Wallgren A, Arner O, Bergsrom J, Blomstedt B: The value of preoperative radiotherapy in operable mammary carcinoma. Int J Radiat Oncol Biol Phys 3:287–290, 1980
Host H, Brennhovd IO: The effect of post-operative radiotherapy in breast cancer. Int J Radiat Oncol Biol Phys 2:1061–1067, 1977
Lacour J, Bucalossi P, Caceres E, Jacobelli G, Koszarowski, Le M, Rumaeu-Rouquette C, Veronesi U: Radical mastectomy versus radical mastectomy plus internal mammary dissection: five-year results of an international cooperative study. Cancer 37:206–214, 1976
Fisher B, Wolmark N, Redmond C, Deutsch M, Fisher E, and Participating NSABP Investigators: Findings from NSABP Protocol No B-04: Comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancer. Cancer 48:1863–1872, 1981
Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, Gallus G, Greco M, Luini A, Marubini E, Muscolino G, Rilke F, Salvadori B, Zecchini A, Zucali R: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. New Engl J Med 305:6–11, 1981